Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides - PubMed (original) (raw)
Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides
Bradley L Hodges et al. Mol Ther. 2004 Aug.
Free article
Abstract
CpG-reduced, CMV-based plasmid DNA constructs encoding human alpha-galactosidase A and factor IX were injected into C57Bl/6, BALB/c, and CD1 mice using hydrodynamics-based delivery of plasmid DNA (pDNA), and gene expression was monitored for 6 months. Linearized and supercoiled pDNAs were compared for their abilities to support long-term expression and to generate immune responses to the transgene product. In all mouse strains supercoiled CpG-reduced pDNA encoding alpha-galactosidase A and factor IX generated higher and more sustained levels of circulating gene product than their supercoiled CpG-replete analogs. Linearizing supercoiled CpG-reduced pDNA did not significantly increase levels of circulating gene product beyond levels supercoiled CpG-reduced pDNA could achieve. Linearizing supercoiled CpG-replete pDNA vectors significantly increased expression compared to their supercoiled CpG-replete analogs, but the increase was short-lived or subtherapeutic. Regardless of vector, liver depot expression did not elicit significant antibody responses to human alpha-galactosidase A or factor IX. Taken together, these data suggest that a clinically acceptable hydrodynamics-based approach targeting the liver combined with CpG-reduced pDNA vectors may represent a viable option for individuals with hemophilia, a lysosomal storage disease, or other disease in which prolonged depot expression of a therapeutic protein from the liver is desirable.
Copyright The American Society of Gene Therapy
Similar articles
- High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS, Przybylska M, Ziegler RJ, Liu D, Cheng SH. Yew NS, et al. Mol Ther. 2001 Jul;4(1):75-82. doi: 10.1006/mthe.2001.0415. Mol Ther. 2001. PMID: 11472109 - CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
Reyes-Sandoval A, Ertl HC. Reyes-Sandoval A, et al. Mol Ther. 2004 Feb;9(2):249-61. doi: 10.1016/j.ymthe.2003.11.008. Mol Ther. 2004. PMID: 14759809 - Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS, Marshall J, Przybylska M, Wysokenski DM, Ziegler RJ, Rafter PW, Li C, Armentano D, Cheng SH. Yew NS, et al. Hum Gene Ther. 1999 Jul 20;10(11):1833-43. doi: 10.1089/10430349950017518. Hum Gene Ther. 1999. PMID: 10446923 - CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.
Hyde SC, Pringle IA, Abdullah S, Lawton AE, Davies LA, Varathalingam A, Nunez-Alonso G, Green AM, Bazzani RP, Sumner-Jones SG, Chan M, Li H, Yew NS, Cheng SH, Boyd AC, Davies JC, Griesenbach U, Porteous DJ, Sheppard DN, Munkonge FM, Alton EW, Gill DR. Hyde SC, et al. Nat Biotechnol. 2008 May;26(5):549-51. doi: 10.1038/nbt1399. Epub 2008 Apr 27. Nat Biotechnol. 2008. PMID: 18438402 Review. - A novel gene expression system: non-viral gene transfer for hemophilia as model systems.
Miao CH. Miao CH. Adv Genet. 2005;54:143-77. doi: 10.1016/S0065-2660(05)54007-0. Adv Genet. 2005. PMID: 16096011 Review.
Cited by
- Suitable Promoter for DNA Vaccination Using a pDNA Ternary Complex.
Kurosaki T, Nakamura H, Sasaki H, Kodama Y. Kurosaki T, et al. Pharmaceutics. 2024 May 17;16(5):679. doi: 10.3390/pharmaceutics16050679. Pharmaceutics. 2024. PMID: 38794341 Free PMC article. - Selection on synonymous sites: the unwanted transcript hypothesis.
Radrizzani S, Kudla G, Izsvák Z, Hurst LD. Radrizzani S, et al. Nat Rev Genet. 2024 Jun;25(6):431-448. doi: 10.1038/s41576-023-00686-7. Epub 2024 Jan 31. Nat Rev Genet. 2024. PMID: 38297070 Review. - Construction and characterization of a novel miniaturized filamentous phagemid for targeted mammalian gene transfer.
Wong S, Jimenez S, Slavcev RA. Wong S, et al. Microb Cell Fact. 2023 Jul 10;22(1):124. doi: 10.1186/s12934-023-02135-w. Microb Cell Fact. 2023. PMID: 37430278 Free PMC article. - Current strategies employed in the manipulation of gene expression for clinical purposes.
Tsai HC, Pietrobon V, Peng M, Wang S, Zhao L, Marincola FM, Cai Q. Tsai HC, et al. J Transl Med. 2022 Nov 18;20(1):535. doi: 10.1186/s12967-022-03747-3. J Transl Med. 2022. PMID: 36401279 Free PMC article. Review. - Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma.
Vaughan HJ, Zamboni CG, Hassan LF, Radant NP, Jacob D, Mease RC, Minn I, Tzeng SY, Gabrielson KL, Bhardwaj P, Guo X, Francisco D, Pomper MG, Green JJ. Vaughan HJ, et al. Sci Adv. 2022 Jul 22;8(29):eabo6406. doi: 10.1126/sciadv.abo6406. Epub 2022 Jul 20. Sci Adv. 2022. PMID: 35857843 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical